NEW YORK, Nov 29 –DeCode Genetics, in an effort to transform its raw population genomics data into revenue-generating products, has launched two new subsidiaries: Encode for pharmacogenic studies and DeCode Cancer for developing cancer diagnostic and therapeutic products, the company said Wednesday.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.